†Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom.
§Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales 2052, Australia.
J Am Chem Soc. 2015 Apr 1;137(12):4215-22. doi: 10.1021/jacs.5b01140. Epub 2015 Mar 20.
The entropy-driven affinity of trivalent (in)organic arsenicals for closely spaced dithiols has been exploited to develop a novel route to peptide/protein-polymer conjugation. A trivalent arsenous acid (As(III)) derivative (1) obtained from p-arsanilic acid (As(V)) was shown to readily undergo conjugation to the therapeutic peptide salmon calcitonin (sCT) via bridging of the Cys(1)-Cys(7) disulfide, which was verified by RP-HPLC and MALDI-ToF-MS. Conjugation was shown to proceed rapidly (t < 2 min) in situ and stoichiometrically through sequential reduction-conjugation protocols, therefore exhibiting conjugation efficiencies equivalent to those reported for the current leading disulfide-bond targeting strategies. Furthermore, using bovine serum albumin as a model protein, the trivalent organic arsenical 1 was found to demonstrate enhanced specificity for disulfide-bond bridging in the presence of free cysteine residues relative to established maleimide functional reagents. This specificity represents a shift toward potential orthogonality, by clearly distinguishing between the reactivity of mono- and disulfide-derived (vicinal or neighbors-through-space) dithiols. Finally, p-arsanilic acid was transformed into an initiator for aqueous single electron-transfer living radical polymerization, allowing the synthesis of hydrophilic arsenic-functional polymers which were shown to exhibit negligible cytotoxicity relative to a small molecule organic arsenical, and an unfunctionalized polymer control. Poly(poly[ethylene glycol] methyl ether acrylate) (PPEGA480, DPn = 10, Mn,NMR = 4900 g·mol(-1), Đ = 1.07) possessing a pentavalent arsenic acid (As(V)) α-chain end was transformed into trivalent As(III) post-polymerization via initial reduction by biological reducing agent glutathione (GSH), followed by binding of GSH. Conjugation of the resulting As(III)-functional polymer to sCT was realized within 35 min as indicated by RP-HPLC and verified later by thermodynamically driven release of sCT, from the conjugate, in the presence of strong chelating reagent ethanedithiol.
三价(无机)有机胂化物与紧密间隔的二硫醇的熵驱动亲和力已被用于开发一种新的肽/蛋白质-聚合物偶联方法。从对氨基苯胂酸(As(V))获得的三价亚砷酸(As(III))衍生物(1)被证明可以通过桥接 Cys(1)-Cys(7)二硫键,快速(t < 2 分钟)原位和化学计量地与治疗性肽鲑鱼降钙素(sCT)进行偶联,这通过反相高效液相色谱法(RP-HPLC)和基质辅助激光解吸电离飞行时间质谱法(MALDI-ToF-MS)得到验证。偶联反应通过连续的还原-偶联方案快速进行(t < 2 分钟),并且具有与当前领先的二硫键靶向策略相当的偶联效率。此外,使用牛血清白蛋白作为模型蛋白,与已建立的马来酰亚胺功能试剂相比,三价有机胂化物 1 被发现对游离半胱氨酸残基存在时的二硫键桥接具有增强的特异性。这种特异性代表了向潜在正交性的转变,因为它清楚地区分了单硫和双硫(邻位或空间邻位)二硫醇的反应性。最后,对氨基苯胂酸被转化为水性单电子转移活自由基聚合的引发剂,允许合成亲水性砷功能聚合物,与小分子有机胂化物相比,其表现出可忽略的细胞毒性,且无功能聚合物对照。聚(聚乙二醇)甲基醚丙烯酸酯(PPEGA480,DPn = 10,Mn,NMR = 4900 g·mol(-1),Đ = 1.07)具有五价砷酸(As(V))α-链末端,通过生物还原剂谷胱甘肽(GSH)的初始还原,然后通过 GSH 的结合,在聚合后转化为三价 As(III)。通过反相高效液相色谱法(RP-HPLC)可以观察到 35 分钟内,As(III)功能聚合物与 sCT 的偶联反应,随后在强螯合剂乙二硫醇的存在下,通过热力学驱动从偶联物中释放 sCT 进行验证。